Neuromyelitis Optica Spectrum Disorders
📧 Sign up to get email alerts when something new happens for Neuromyelitis Optica Spectrum Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders [Phase 1]
A Phase 1 clinical trial assessing the safety and efficacy of NouvSoma001 for neuromyelitis optica spectrum disorders is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)
Beijing Tiantan Hospital is conducting an ongoing enrollment study to establish normal Chinese lifespan brain charts, enrolling by invitatio…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD [Phase 3]
Phase 3 clinical trial evaluating the efficacy, safety, pharmacokinetics, pharmacodynamics, and anti-drug antibodies of eculizumab in Chines…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)
A prospective cohort study investigating neuromyelitis optica spectrum disorders (NMOSD) is listed as not yet recruiting, sponsored by Xiame…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
An ongoing sponsor-initiated study is evaluating metabolism, connectivity, and ultra-high-field mesoscopic imaging to uncover mechanisms of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility
This update summarizes a completed clinical trial evaluating the impact of multiple sclerosis and its treatments on women's fertility.
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD [Phase 3]
Phase 3 trial update examining slow vs rapid glucocorticoid tapering in NMOSD patients treated with inebilizumab. The study is not yet recru…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy [Phase 1]
Phase 1 clinical trial investigating C-CAR168 for autoimmune diseases refractory to standard therapy is currently recruiting, covering SLE, …
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders [Phase 1]
A Phase I trial evaluating BAT4406F injection in patients with Neuromyelitis Optica Spectrum Disorders has completed.
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder [NA]
Clinical trial status update indicates a study evaluating Protein A immunoadsorption for acute episodes of Neuromyelitis Optica Spectrum Dis…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: BLAZE-Limiting Approach in NMOSD
This clinical trial update notes the completed status of the BLAZE-Limiting Approach study in neuromyelitis optica spectrum disorders (NMOSD…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: HANDLE-a Real World Study on Satralizumab in NMOSD
A real-world study assessing satralizumab for neuromyelitis optica spectrum disorders is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis. [NA]
This clinical trial update reports on the frequency of FCGR3A gene polymorphisms in patients with Neuromyelitis Optica Spectrum Disorders, M…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. [EARLY_Phase 1]
A Phase 1 trial evaluating universal CAR-T cells for refractory autoimmune diseases of the nervous system; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE) [Phase 3]
This document provides an update on a Phase 3 trial evaluating the efficacy and safety of Divozilimab in patients with Neuromyelitis Optica …
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD [Phase 1, Phase 2]
A longitudinal Phase 1/2 trial evaluating ACTEMRA (tocilizumab) as monotherapy in highly active neuromyelitis optica spectrum disorders has …
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders [Phase 4]
A Phase 4 clinical trial update for ineibilizumab in neuromyelitis optica spectrum disorders is in progress, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: An Open Label Study of the Effects of SHR1459 in NMOSDs Patients [Phase 2]
Open-label Phase 2 trial assessing the effects of SHR1459 in patients with Neuromyelitis Optica Spectrum Disorders has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating inebilizumab for Neuromyelitis Optica Spectrum Disorders.
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders [Phase 2, Phase 3]
A Phase 2/3 trial comparing tocilizumab to azathioprine in neuromyelitis optica spectrum disorders (NMOSD) has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders [Phase 2]
Phase 2 clinical trial evaluating autologous mesenchymal stem cells for neuromyelitis optica spectrum disorders (Devic's syndrome).